Andreas Hüser

Treatment of primary Sjögren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity

Thomas Dörner, Maximilian Posch, Yue Li et al. · Annals of the Rheumatic Diseases · 2019 · 189 citations

Baculovirus-based Vaccination Vectors Allow for Efficient Induction of Immune Responses Against Plasmodium falciparum Circumsporozoite Protein

Robert Strauss, Andreas Hüser, Shaoheng Ni et al. · Molecular Therapy · 2006 · 129 citations · Full text

Incorporation of decay-accelerating factor into the baculovirus envelope generates complement-resistant gene transfer vectors

Andreas Hüser, Michael Rudolph, Christian Hofmann · Nature Biotechnology · 2001 · 118 citations

Molecular Virology, Decay-accelerating Factor, Pathogenesis +8

Safety, pharmacokinetics, and antiretroviral activity of islatravir (ISL, MK-8591), a novel nucleoside reverse transcriptase translocation inhibitor, following single-dose administration to treatment-naive adults infected with HIV-1: an open-label, phase 1b, consecutive-panel trial

Dirk Schürmann, Deanne Jackson Rudd, Saijuan Zhang et al. · The Lancet HIV · 2020 · 88 citations

Phase 1B, Pharmacology, Antiviral Drug Development +8

Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.

Andreas Hüser, Christian Hofmann · PubMed · 2003 · 66 citations